Literature DB >> 1376417

Assessment of antimutagenicity and anticarcinogenicity.

S De Flora1, G Bronzetti, F H Sobels.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1376417     DOI： 10.1016/0027-5107(92)90059-b

Source DB:  PubMed          Journal:  Mutat Res        ISSN： 0027-5107            Impact factor:   2.433


× No keyword cloud information.
  5 in total

Review 1.  Antimutagenic compounds and their possible mechanisms of action.

Authors:  Karolina Słoczyńska; Beata Powroźnik; Elżbieta Pękala; Anna M Waszkielewicz
Journal:  J Appl Genet       Date:  2014-03-11       Impact factor: 3.240

2.  The correlation between antimutagenic activity and total phenolic content of extracts of 31 plant species with high antioxidant activity.

Authors:  Tshepiso Jan Makhafola; Esameldin Elzein Elgorashi; Lyndy Joy McGaw; Luc Verschaeve; Jacobus Nicolaas Eloff
Journal:  BMC Complement Altern Med       Date:  2016-11-29       Impact factor: 3.659

3.  Isolation and characterization of the compounds responsible for the antimutagenic activity of Combretum microphyllum (Combretaceae) leaf extracts.

Authors:  Tshepiso Jan Makhafola; Esameldin Elzein Elgorashi; Lyndy Joy McGaw; Maurice Ducret Awouafack; Luc Verschaeve; Jacobus Nicolaas Eloff
Journal:  BMC Complement Altern Med       Date:  2017-09-06       Impact factor: 3.659

4.  Atorvastatin Downregulates In Vitro Methyl Methanesulfonate and Cyclophosphamide Alkylation-Mediated Cellular and DNA Injuries.

Authors:  Carlos F Araujo-Lima; Larissa S A Christoni; Graça Justo; Maria N C Soeiro; Claudia A F Aiub; Israel Felzenszwalb
Journal:  Oxid Med Cell Longev       Date:  2018-04-03       Impact factor: 6.543

5.  The influence of organic solvents on estimates of genotoxicity and antigenotoxicity in the SOS chromotest.

Authors:  Nathalia Quintero; Elena E Stashenko; Jorge Luis Fuentes
Journal:  Genet Mol Biol       Date:  2012-06-23       Impact factor: 1.771
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.